Effect of bolus and divided feeding on urine ions and supersaturation in genetic hypercalciuric stone-forming rats

Kidney International

Volumn 73, Issue 4, 2008, Pages 423-429

  Bushinsky, D A ^a   Michalenka, A C ^a   Strutz, K L ^a   Donahue, S ^b   Asplin, J R ^b  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b LithoLink Corporation   (United States)

Author keywords

Calcium; Calcium oxalate; Hypercalciuria; Kidney stones; Nephrolithiasis

Indexed keywords

CALCIUM OXALATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM EXCRETION; CALCIUM INTAKE; CALCIUM URINE LEVEL; CONTROLLED STUDY; FEEDING; FEMALE; HYPERCALCIURIA; NEPHROLITHIASIS; NONHUMAN; POSTPRANDIAL STATE; PRIORITY JOURNAL; RAT; STONE FORMATION; URINALYSIS; URINARY EXCRETION;

EID: 38749127588     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5002699     Document Type: Article

References (58)

1. Monk RD, Bushinsky DA. Kidney stones. In: Larsen PR, Kronenberg HM, Melmed S, Polonsky KS (eds). Williams Textbook of Endocrinology, 10th edn, W.B. Saunders: Philadelphia, 2003, pp 1411-1425.
2. Monk RD, Bushinsky DA. Nephrolithiasis and nephrocalcinosis. In: Johnson R, Frehally J (eds). Comprehensive Clinical Nephrology, 2nd edn, Mosby: London, 2003, pp 731-744.
3. Bushinsky DA. Nephrolithiasis. J Am Soc Nephrol 1998; 9: 917-924.
4. Coe FL, Favus MJ, Asplin JR. Nephrolithiasis. In: Brenner BM (ed). The Kidney, 7th edn, W.B. Saunders Company: Philadelphia, 2004, pp 1819-1866.
5. Bushinsky DA. Renal lithiasis. In: Humes HD (ed). Kelly's Textbook of Medicine. Lippincott Williams & Wilkens: New York, 2000, pp 1243-1248.
6. Bushinsky DA, Favus MJ. Mechanism of hypercalciuria in genetic hypercalciuric rats: inherited defect in intestinal calcium transport. J Clin Invest 1988; 82: 1585-1591.
7. Kim M, Sessler NE, Tembe V et al. Response of genetic hypercalciuric rats to a low calcium diet. Kidney Int 1993; 43: 189-196.
8. Li X-Q, Tembe V, Horwitz GM et al. Increased intestinal vitamin D receptor in genetic hypercalciuric rats: a cause of intestinal calcium hyperabsorption. J Clin Invest 1993; 91: 661-667.
9. Bushinsky DA, Kim M, Sessler NE et al. Increased urinary saturation and kidney calcium content in genetic hypercalciuric rats. Kidney Int 1994; 45: 58-65.
10. Bushinsky DA, Grynpas MD, Nilsson EL et al. Stone formation in genetic hypercalciuric rats. Kidney Int 1995; 48: 1705-1713.
11. 3 in bone from genetic hypercalciuric rats. Am J Physiol (Cell Physiol) 1996; 271: C130-C135.
12. Bushinsky DA, Bashir MA, Riordon DR et al. Increased dietary oxalate does not increase urinary calcium oxalate saturation in hypercalciuric rats. Kidney Int 1999; 55: 602-612.
13. Bushinsky DA. Genetic hypercalciuric stone forming rats. Semin Nephrol 1996; 16: 448-457.
14. Asplin JR, Bushinsky DA, Singharetnam W et al. Relationship between supersaturation and crystal inhibition in hypercalciuric rats. Kidney Int 1997; 51: 640-645.
15. Tsuruoka S, Bushinsky DA, Schwartz GJ. Defective renal calcium reabsorption in genetic hypercalciuric rats. Kidney Int 1997; 51: 1540-1547.
16. Bushinsky DA, Neumann KJ, Asplin J, Krieger NS. Alendronate decreases urine calcium and supersaturation in genetic hypercalciuric rats. Kidney Int 1999; 55: 234-243.
17. 3: A new characteristic of genetic hypercalciuric stone-forming rats. J Clin Invest 1998; 101: 2223-2232.
18. Evan AP, Bledsoe SB, Smith SB, Bushinsky DA. Calcium oxalate crystal localization and osteopontin immunostaining in genetic hypercalciuric stone-forming rats. Kidney Int 2004; 65: 154-161.
19. Bushinsky DA. Genetic hypercalciuric stone-forming rats. Curr Opin Nephrol Hypertens 1999; 8: 479-488.
20. Bushinsky DA, Parker WR, Asplin JR. Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats. Kidney Int 2000; 57: 550-560.
21. Bushinsky DA, Grynpas MD, Asplin JR. Effect of acidosis on urine supersaturation and stone formation in genetic hypercalciuric stone forming rats. Kidney Int 2001; 59: 1415-1423.
22. Bushinsky DA, Asplin JR, Grynpas MD et al. Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats. Kidney Int 2002; 61: 975-987.
23. 3 in genetic hypercalciuric stone-forming rats. J Am Soc Nephrol 2005; 16: 1300-1308.
24. Bushinsky DA, Asplin JR. Thiazides reduce brushite, but not calcium oxalate, supersaturation and stone formation in genetic hypercalciuric stone-forming rats. J Am Soc Nephrol 2005; 16: 417-424.
25. Karnauskas AJ, van Leeuwen JP, van den Bemd GJ et al. Mechanism and function of high vitamin D receptor levels in genetic hypercalciuric stone-forming rats. J Bone Miner Res 2005; 20: 447-454.
26. Bushinsky DA, LaPlante K, Asplin JR. Effect of cinacalcet on urine calcium excretion and supersaturation in genetic hypercalciuric stone-forming rats. Kidney Int 2006; 69: 1586-1592.
27. Bushinsky DA, Frick KK, Nehrke K. Genetic hypercalciuric stone-forming rats. Curr Opin Nephrol Hypertens 2006; 15: 403-418.
28. Hoopes Jr RR, Middleton FA, Sen S et al. Isolation and confirmation of a calcium excretion quantitative trait locus on chromosome 1 in genetic hypercalciuric stone-forming congenic rats. J Am Soc Nephrol 2006; 17: 1292-1304.
29. Hagler L, Herman RH. Oxalate metabolism. I. Am J Clin Nutr 1973; 26: 758-765.
30. Bushinsky DA. Recurrent hypercalciuric nephrolithiasis - does diet help? N Engl J Med 2002; 346: 124-125.
31. Bushinsky DA. Nephrolithiasis: site of the initial solid phase. J Clin Invest 2003; 111: 602-605.
32. Monk RD, Bushinsky DA. Pathogenesis of idiopathic hypercalciuria. In: Coe F, Favus M, Pak C, Parks J, Preminger G (eds). Kidney Stones: Medical and Surgical Management. Lippincott-Raven: Philadelphia, 1996, pp 759-772.
33. Coe FL, Bushinsky DA. Pathophysiology of hypercalciuria. Am J Physiol (Renal Fluid Electrolyte Physiol) 1984; 247: F1-F13.
34. Evan AP, Lingeman JE, Coe FL et al. Randall's plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest 2003; 111: 607-616.
35. Bushinsky DA. Calcium, magnesium, and phosphorus: renal handling and urinary excretion. In: Favus MJ (ed). Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 5th edn, American Society for Bone and Mineral Research: Washington, DC, 2003, pp 97-105.
36. Monk RD, Bushinsky DA. Treatment of calcium, phosphorus, and magnesium disorders. In: Halperin M (ed). Therapy in Nephrology and Hypertension: A Companion to Brenner and Rector's The Kidney. W.B. Saunders Company: Philadelphia, 1999, pp 303-315.
37. Bushinsky DA, Monk RD. Electrolyte quintet: Calcium. Lancet 1998; 352: 306-311.
38. Bushinsky DA. Disorders of calcium and phosphorus homeostasis. In: Greenberg A (ed). Primer on Kidney Diseases, 4th edn, Academic Press: San Diego, 2005, pp 120-130.
39. Worcester EM, Gillen DL, Evan AP et al. Evidence that postprandial reduction of renal calcium reabsorption mediates hypercalciuria of patients with calcium nephrolithiasis. Am J Physiol Renal Physiol 2007; 292: F66-F75.
40. Bronner F. Mechanisms of intestinal calcium absorption. J Cell Biochem 2003; 88: 387-393.
41. Lemann Jr J, Pleuss JA, Worcester EA et al. Urinary oxalate excretion increases with body size and decreases with increasing dietary calcium intake among healthy adults. [published erratum appears in Kidney Int 1996; 50: 341]. Kidney Int 1996; 49: 200-208.
42. Procino G, Carmosino M, Tamma G et al. Extracellular calcium antagonizes forskolin-induced aquaporin 2 trafficking in collecting duct cells. Kidney Int 2004; 66: 2245-2255.
43. Michalylova V, Ilkova P. Photometric determination of microamounts of calcium with arsenazo III. Anal Chim Acta 1971; 53: 194-198.
44. Heinegard D, Tiderstrom G. Determination of serum creatinine by a direct colorimetric method. Clin Chim Acta 1973; 43: 305-310.
45. Ichida T, Hine N. Improvement of Baginski's method for phosphorus determination. Clin Chim Acta 1969; 23: 378-379.
46. Fossati P, Prencipe L, Berti G. Use of 3,5-dichloro-2- hydroxybenzenesulfonic acid/4-aminophenazone chromogenic system in direct enzymic assay of uric acid in serum and urine. Clin Chem 1980; 26: 227-231.
47. Abernathy MH, Fowler RT. Micellar improvement of the calmagite compleximetric measurement of magnesium in plasma. Clin Chem 1982; 28: 520-522.
48. Ratliff CR, Hall FF. Ammonia in plasma enzymatic procedure. Selected Methods Clin Chem 1982; 9: 85-90.
49. Eisenman G, Rudin DO, Casby JU. Glass electrode for measuring sodium ion. Science 1957; 126: 831-834.
50. Stefanac Z, Simon W. Highly selective cation electrode systems based on in-vitro behavior of macrotetrolides in membranes. Chimica 1966; 20: 436-440.
51. Cotlove E. Chloride. In: Seligson D (ed). Standard Methods in Clinical Chemistry. Academic Press: New York, 1961, pp 81-92.
52. Jiang Z, Asplin JR, Evan AP et al. Calcium oxalate urolithiasis in mice lacking anion transporter Slc26a6. Nat Genet 2006; 38: 474-478.
53. Finlayson B. Calcium stones: some physical and clinical aspects. In: David DS (ed). Calcium Metabolism in Renal Failure and Nephrolithiasis. Wiley: New York, 1977, pp 337-382.
54. Werness PG, Brown CM, Smith LH, Finlayson B. EQUIL2: a BASIC computer program for the calculation of urinary saturation. J Urol 1985; 134: 1242-1244.
55. Brown CM, Ackermann DK, Purich DL. EQUIL93: a tool for experimental and clinical urolithiasis. Urol Res 1994; 22: 119-126.
56. 44Ca labeling of bone by scanning ion microprobe. Am J Physiol (Endoc rinol Metab 22) 1990; 259: E586-E592.
57. Bushinsky DA, Lechleider RJ. Mechanism of proton-induced bone calcium release: calcium carbonate-dissolution. Am J Physiol (Renal Fluid Electrolyte Physiol 22) 1987; 253: F998-F1005.
58. Bushinsky DA, Gavrilov K, Chabala JM et al. Effect of metabolic acidosis on the potassium content of bone. J Bone Miner Res 1997; 12: 1664-1671.